Treatment of thrombosis of veins of the lower extremities.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D003911:Dextrans / Q000627:therapeutic use; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D007866:Leg / Q000098:blood supply*; D008026:Ligation; D010689:Phlebitis / Q000628:therapy; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy; D011644:Puerperal Disorders / Q000188:drug therapy; D011655:Pulmonary Embolism / Q000517:prevention & control; D013300:Streptokinase / Q000627:therapeutic use; D013924:Thrombophlebitis / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D013997:Time Factors; D014568:Urokinase-Type Plasminogen Activator / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D003911:Dextrans; D006493:Heparin; D013300:Streptokinase; D014568:Urokinase-Type Plasminogen Activator